AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 230 filers reported holding AMICUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,486,037 | -2.0% | 122,207 | +1.2% | 0.08% | +1.2% |
| Q2 2023 | $1,516,356 | +20.5% | 120,729 | +6.4% | 0.08% | +3.8% |
| Q1 2023 | $1,258,061 | +335.5% | 113,441 | +379.5% | 0.08% | +310.5% |
| Q4 2022 | $288,864 | +24.0% | 23,658 | +6.1% | 0.02% | +11.8% |
| Q3 2022 | $233,000 | -4.1% | 22,291 | -1.5% | 0.02% | +13.3% |
| Q2 2022 | $243,000 | +11.5% | 22,640 | -1.5% | 0.02% | +66.7% |
| Q1 2022 | $218,000 | -23.2% | 22,991 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $284,000 | +29.7% | 24,627 | +7.6% | 0.01% | +28.6% |
| Q3 2021 | $219,000 | -16.4% | 22,892 | -16.0% | 0.01% | -22.2% |
| Q2 2021 | $262,000 | +6.5% | 27,252 | +9.5% | 0.01% | 0.0% |
| Q1 2021 | $246,000 | -54.7% | 24,881 | +5.8% | 0.01% | -62.5% |
| Q4 2020 | $543,000 | +73.5% | 23,509 | +6.2% | 0.02% | +50.0% |
| Q3 2020 | $313,000 | -10.8% | 22,138 | -5.0% | 0.02% | -20.0% |
| Q2 2020 | $351,000 | +74.6% | 23,302 | +7.2% | 0.02% | +33.3% |
| Q1 2020 | $201,000 | -16.9% | 21,731 | -12.4% | 0.02% | +36.4% |
| Q4 2019 | $242,000 | +47.6% | 24,809 | +21.3% | 0.01% | +37.5% |
| Q3 2019 | $164,000 | -42.5% | 20,457 | -10.5% | 0.01% | -42.9% |
| Q2 2019 | $285,000 | +3.3% | 22,860 | +12.5% | 0.01% | +7.7% |
| Q1 2019 | $276,000 | +4.9% | 20,314 | -25.9% | 0.01% | -18.8% |
| Q4 2018 | $263,000 | -42.3% | 27,430 | -27.2% | 0.02% | -5.9% |
| Q3 2018 | $456,000 | – | 37,681 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |